PREVAIL THERAPEUTICS INC's ticker is PRVL and the CUSIP is 74140Y101. A total of 77 filers reported holding PREVAIL THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $64,365,000 | +88.3% | 2,790 | -16.9% | 0.00% | – |
| Q3 2020 | $34,174,000 | +303.8% | 3,357 | +491.0% | 0.00% | – |
| Q2 2020 | $8,463,000 | -83.2% | 568 | -86.3% | 0.00% | – |
| Q1 2020 | $50,491,000 | +269.6% | 4,142 | +380.0% | 0.00% | – |
| Q4 2019 | $13,661,000 | +18.6% | 863 | -8.0% | 0.00% | – |
| Q3 2019 | $11,519,000 | – | 938 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|